Tag: BÜHLMANN IBDoc®

IBDoc and Me

Health Canada Licence: 98903, Device class: 3 IBDoc® is not available for sale in the US. Read perspectives and insights from a patient from the UK who has been using IBDoc® since last October and is trying this new tool to monitor his Crohn’s Disease. He has been documenting his experiences in a blog to share his

BUHLMANN LabSense News Winter 2018 Edition

BUHLMANN Diagnostics Corp is proud to release the sixth edition of our newsletter. View the latest information, new happenings, products highlights, citations, and promotions in the BUHLMANN LabSense News. Check Out LabSense News Today! What's New Introducing BAT in Food Allergy Webinar recording and eBook by Dr. Alexandra Santos as well as two new IBDoc® Posters

BÜHLMANN Laboratories AG (BL), based in Basel Switzerland, has been discovering, developing & manufacturing innovative chemistry and immunological in-vitro diagnostic (IVD) and research use only (RUO) assays for almost 50 years (circa 1976). As the United States commercial affiliate of BL, BUHLMANN Diagnostics Corp (BDC), based in Amherst, NH is committed to providing exceptional sales, support, and technical services to our clinical, discovery and basic science research laboratory customers.

Tag: BÜHLMANN IBDoc®

IBDoc and Me

BUHLMANN LabSense News Winter 2018 Edition

ABOUT US

SOCIAL MEDIA

QUICK LINKS

CONTACT US